Qihuang Needle Therapy for Parkinson's Disease: Clinical Trial Protocol

A 2026 protocol document for a randomized controlled trial investigating a novel acupuncture technique for Parkinson's disease. The study, authored by Wanqing Peng, involves 69 patients and uses multimodal MRI to assess neuroplasticity mechanisms alongside clinical symptom scales. The document is a 104.0 KB PDF published under a CC-BY-4.0 license.

Use Cases

• Analyzing clinical trial design for acupuncture interventions based on the described triple-arm randomized controlled trial structure.
• Studying neuroimaging biomarker selection for Parkinson's disease based on the multimodal MRI markers mentioned (gray matter volume, functional connectivity).
• Reviewing integration of traditional and Western medicine assessment based on the combination of UPDRS-III, NMSS, and PDQ-39 clinical scales.
• Examining protocol details for mechanistic evidence generation based on the described integration of Qihuang needle therapy with advanced neuroimaging.

Strengths

• Protocol is clearly structured with a defined sample size of 69 patients.
• Describes a specific, multi-faceted assessment approach combining clinical scales, gait analysis, and multiple MRI modalities.
• Document is openly licensed (CC-BY-4.0) for reuse and analysis.

Limitations

• The dataset is a protocol document (104.0 KB PDF), not the resulting clinical or imaging data.
• Column-level documentation for any eventual data is absent; field semantics must be inferred after download.
• Row count for any future data is unknown, which may limit suitability assessment.

Provenance

Source

figshare, author Wanqing Peng.

Collection Method

Described as a clinical trial protocol document.

Time Range

Protocol published in 2026; trial timeframe not specified.

Freshness

Last updated 2026-04 13:15:22.

Geography

Geographic coverage of the trial is not specified.